Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Pfizer Inc. (NYSE:PFE)’s chief executive acknowledged Tuesday that a potential merger with AstraZeneca would lead to job losses, but promised to keep key research jobs in Britain as part of its $106 billion takeover bid. Pfizer Inc. (NYSE:PFE) stock performance was 0.24% in last session and finished the day at $29.20. Traded volume was 26.29million shares in the last session and the average volume of … Continue reading Healthcare Active Stocks: Pfizer Inc. (NYSE:PFE), Merck & Co., Inc. (NYSE:MRK), Gilead Sciences (NASDAQ:GILD), MannKind Corporation (NASDAQ:MNKD)

Pharma Stocks on Watch: Biota Pharmaceuticals Inc(NASDAQ:BOTA), Merck & Co., Inc.(NYSE:MRK), Intercept Pharmaceuticals Inc(NASDAQ:ICPT), Pfizer Inc.(NYSE:PFE)

Biota Pharmaceuticals Inc(NASDAQ:BOTA) announced that an interim update has been provided from the U.S. Department of Health and Human Services and the Biomedical Advanced Research and Development Authority, or BARDA, with respect to the Stop-Work Order the company recently received from BARDA and its pending decision regarding a recent In Process Review of its contract to support the development of laninamivir octanoate. Biota Pharmaceuticals Inc(NASDAQ:BOTA) has … Continue reading Pharma Stocks on Watch: Biota Pharmaceuticals Inc(NASDAQ:BOTA), Merck & Co., Inc.(NYSE:MRK), Intercept Pharmaceuticals Inc(NASDAQ:ICPT), Pfizer Inc.(NYSE:PFE)

As the European Central Bank prepares to take over supervision of about 130 euro-area lenders from BNP Paribas to National Bank of Greece (ADR) (NYSE:NBG) starting in November, regulators have sought to compile the toughest stress tests in a bid to repair credibility damaged by assessments in 2010 and 2011 that didn’t uncover weaknesses at banks that later failed. National Bank of Greece (ADR) (NYSE:NBG) … Continue reading Hot Stocks: National Bank of Greece (NYSE:NBG), Exxon Mobil Corporation (NYSE:XOM), Merck & Co. (NYSE:MRK), Hewlett-Packard Company (NYSE:HPQ)

Gilead Sciences, Inc. (NASDAQ:GILD) announced data from two Phase 2 studies and a compassionate access study in which a regimen containing once-daily Sovaldi(R) (sofosbuvir) 400 mg was administered for the treatment of chronic hepatitis C virus (HCV) infection in patients with advanced liver disease. Gilead Sciences, Inc. (NASDAQ:GILD) stock performance was -7.32% in last session and finished the day at $65.48. Traded volume was 43.15million … Continue reading Healthcare Active Runners: Gilead Sciences (NASDAQ:GILD), Pfizer Inc. (NYSE:PFE), Merck & Co. (NYSE:MRK), MannKind Corporation (NASDAQ:MNKD)

On Monday, Johnson & Johnson (NYSE:JNJ) announced that it accepted the binding offer from The Carlyle Group (NASDAQ:CG), which was received and announced on January 16, 2014, to acquire its Ortho-Clinical Diagnostics business for approximately $4 Billion, subject to customary adjustments. Johnson & Johnson (NYSE:JNJ) stock performance was 0.16% in last session and finished the day at $98.42. Traded volume was 10.31million shares in the … Continue reading Healthcare active runners: Johnson & Johnson (NYSE:JNJ), Merck & Co (NYSE:MRK), Pfizer Inc. (NYSE:PFE), MannKind Corporation (NASDAQ:MNKD)

Israel-based Teva Pharmaceutical Industries Ltd. (ADR) (NYSE:TEVA) has announced that the U.S. Supreme Court has granted the Company’s Copaxone certiorari petition, and will hear its appeal of a decision from the United States Court of Appeals for the Federal Circuit that invalidated the claim of U.S. Patent 5,800,808. Teva Pharmaceutical Industries Ltd (ADR) (NYSE:TEVA) stock performance was 1.39% in last session and finished the day … Continue reading Healthcare Active runners: Teva Pharmaceutical Industries (NYSE:TEVA), Bristol-Myers Squibb Co (NYSE:BMY), Merck & Co (NYSE:MRK), Sanofi (NYSE:SNY)